The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
Abstract
A highly specific polyclonal rabbit antiserum directed against murine cachectin/tumor necrosis factor (TNF) was prepared. When BALB/c mice were passively immunized with the antiserum or with purified immune globulin, they were protected against the lethal effect of the endotoxin lipopolysaccharide produced by Escherichia coli . The prophylactic effect was dose-dependent and was most effective when the antiserum was administered prior to the injection of the endotoxin. Antiserum to cachectin/TNF did not mitigate the febrile response of endotoxin-treated animals, and very high doses of endotoxin could overcome the protective effect. The median lethal dose of endotoxin in mice pretreated with 50 microliters of the specific antiserum was approximately 2.5 times greater the median lethal dose for controls given nonimmune serum. The data suggest that cachectin/TNF is one of the principal mediators of the lethal effect of endotoxin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS
LITCHFIELD, J. T., & WILCOXON, F. (1949) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03549-9 · Cited by 7,812
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,558
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,406
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Self-citationBeutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Self-citationGenetic Control of Leucocyte Responses to Endotoxin
SULTZER, B. M. (1968) · Nature · doi:10.1038/2191253a0 · Cited by 375
Studies of endotoxin-induced decrease in lipoprotein lipase activity.
Kawakami, M., & Cerami, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.631 · Cited by 327
Self-citationLipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.
Kawakami, M., Pekala, P. H., Lane, M. D., & Cerami, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.912 · Cited by 267
Self-citationThe determination of the dosage-mortality curve from small numbers
Bliss, C. I. (1938) · Quarterly Journal of Pharmacy and Pharmacology · Cited by 176
Isolation and characterization of a proteolytic enzyme from the adult hookworm Ancylostoma caninum.
Hotez, P. J., Trang, N. L., McKerrow, J. H., & Cerami, A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39614-x · Cited by 102
Self-citation
Cited by
Items 101–200 of 208
Systemic inflammatory response syndrome
Davies, M. G., & Hagen, P.-O. (1997) · Journal of British Surgery · doi:10.1002/bjs.1800840707 · Cited by 456
Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.1859 · Cited by 454
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase
Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T., & Honjo, T. (1999) · Nature Genetics · doi:10.1038/8780 · Cited by 450
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Sherry, B., & Cerami, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1269 · Cited by 432
Self-citationPoltorak, A., Ricciardi-Castagnoli, P., Citterio, S., & Beutler, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040565397 · Cited by 429
Self-citationmiR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
The dark side of C5a in sepsis
Ward, P. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1269 · Cited by 422
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
Tsujimoto, M., Yip, Y. K., & Vilcek, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7626 · Cited by 421
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER
Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., & Fiers, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91850-2 · Cited by 418
Gram-positive and gram-negative bacterial toxins in sepsis: A brief review
Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411
Yang, Y., Liu, B., Dai, J., Srivastava, P. K., Zammit, D. J., Lefrançois, L., & Li, Z. (2007) · Immunity · doi:10.1016/j.immuni.2006.12.005 · Cited by 410
Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., Fuks, Z., & Kolesnick, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1831 · Cited by 408
Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome
Dinarello, C. A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140081040 · Cited by 405
A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., & Kriegler, M. (1990) · Cell · doi:10.1016/0092-8674(90)90158-b · Cited by 403
Dinarello, C. A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1177 · Cited by 397
Perera, P.-Y., Mayadas, T. N., Takeuchi, O., Akira, S., Zaks-Zilberman, M., Goyert, S. M., & Vogel, S. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.574 · Cited by 391
Hyperdynamic Circulation of Liver Disease 40 Years Later: Pathophysiology and Clinical Consequences
Groszmann, R. J. (1994) · Hepatology · doi:10.1002/hep.1840200538 · Cited by 387
Antiviral effects of recombinant tumour necrosis factor in vitro
Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Möller, A., Jacobsen, H., & Kirchner, H. (1986) · Nature · doi:10.1038/323816a0 · Cited by 383
Godin, P. J., & Buchman, T. G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00008 · Cited by 377
Heat Shock Proteins and Cardiovascular Pathophysiology
Snoeckx, L. H. E. H., Cornelussen, R. N., Van Nieuwenhoven, F. A., Reneman, R. S., & Van der Vusse, G. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1461 · Cited by 374
Mackman, N., Brand, K., & Edgington, T. S. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1517 · Cited by 371
The Role of TNF-α in Insulin Resistance
Borst, S. E. (2004) · Endocrine · doi:10.1385/endo:23:2-3:177 · Cited by 369
Nestel, F. P., Price, K. S., Seemayer, T. A., & Lapp, W. S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.405 · Cited by 365
Rosenkranz-Weiss, P., Sessa, W. C., Milstien, S., Kaufman, S., Watson, C. A., & Pober, J. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117221 · Cited by 362
“are responsible for both local and systemic vasodilation in these settings (2-4).”
BackgroundMonocyte deactivation-rationale for a new therapeutic strategy in sepsis
Volk, H. D., Reinke, P., Krausch, D., Zuckermann, H., Asadullah, K., Müller, J. M., Döcke, W. D., & Kox, W. J. (1996) · Intensive Care Medicine · doi:10.1007/bf01743727 · Cited by 361
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003) · Nature Immunology · doi:10.1038/ni910 · Cited by 361
Nakane, A., Minagawa, T., & Kato, K. (1988) · Infection and Immunity · doi:10.1128/iai.56.10.2563-2569.1988 · Cited by 356
Martin, C., Boisson, C., Haccoun, M., Thomachot, L., & Mege, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199711000-00018 · Cited by 356
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76887 · Cited by 354
Kamijo, R., Le, J., Shapiro, D., Havell, E. A., Huang, S., Aguet, M., Bosland, M., & Vilcek, J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1435 · Cited by 351
Camussi, G., Bussolino, F., Salvidio, G., & Baglioni, C. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1390 · Cited by 351
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Exotoxins and endotoxins: Inducers of inflammatory cytokines
Cavaillon, J.-M. (2018) · Toxicon · doi:10.1016/j.toxicon.2017.10.016 · Cited by 346
McMurray, J., Abdullah, I., Dargie, H. J., & Shapiro, D. (1991) · Heart · doi:10.1136/hrt.66.5.356 · Cited by 344
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Bachwich, P. R., Chensue, S. W., Larrick, J. W., & Kunkel, S. L. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90881-8 · Cited by 337
Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors
Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N., & Levitzki, A. (1994) · Science · doi:10.1126/science.8191285 · Cited by 336
Cavaillon, J.-M., Adib-conquy, M., Fitting, C., Adrie, C., & Payen, D. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
Levin, A. D., Wildenberg, M. E., & van den Brink, G. R. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw053 · Cited by 336
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-α
Xaus, J., Comalada, M., Valledor, A. F., Lloberas, J., López-Soriano, F., Argilés, J. M., Bogdan, C., & Celada, A. (2000) · Blood · doi:10.1182/blood.v95.12.3823 · Cited by 331
Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
Stevens, C., Walz, G., Singaram, C., Lipman, M. L., Zanker, B., Muggia, A., Antonioli, D., Peppercorn, M. A., & Strom, T. B. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01300378 · Cited by 331
Zuckerman, S. H., Shellhaas, J., & Butter, L. D. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190213 · Cited by 329
The role of cachectin/TNF in endotoxic shock and cachexia
Ceramil, A., & Beutler, B. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91353-9 · Cited by 328
Self-citationMarks, J. D., Marks, C. B., Ljuce, J. M., Montgomery, A. B., Turner, J., Metz, C. A., & Murray, J. F. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.1.94 · Cited by 328
CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS
van der Poll, T., & van Deventer, S. J. H. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70083-0 · Cited by 323
Interleukin-8 in sepsis: relation to shock and inflammatory mediators
Hack, C. E., Hart, M., van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G., & Aarden, L. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2835-2842.1992 · Cited by 319
Conrad, C., Di Domizio, J., Mylonas, A., Belkhodja, C., Demaria, O., Navarini, A. A., Lapointe, A.-K., French, L. E., Vernez, M., & Gilliet, M. (2018) · Nature Communications · doi:10.1038/s41467-017-02466-4 · Cited by 317
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
Tiegs, G., Wolter, M., & Wendel, A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90208-6 · Cited by 309
Thiemermann, C. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00410-7 · Cited by 303
On the role of macrophages in anthrax.
Hanna, P. C., Acosta, D., & Collier, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10198 · Cited by 301
Tumor necrosis factor and the acute metabolic response to tissue injury in man.
Starnes, H. F., Warren, R. S., Jeevanandam, M., Gabrilove, J. L., Larchian, W., Oettgen, H. F., & Brennan, M. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113733 · Cited by 300
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126975 · Cited by 300
Caplan, M. S., Sun, X.-M., Hsueh, W., & Hageman, J. R. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80661-4 · Cited by 299
Donnahoo, K. K., Meng, X., Ayala, A., Cain, M. P., Harken, A. H., & Meldrum, D. R. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r922 · Cited by 294
Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240524 · Cited by 294
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
Sun, X. M., & Hsueh, W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113459 · Cited by 294
Hermanns, M. I., Unger, R. E., Kehe, K., Peters, K., & Kirkpatrick, C. J. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700081 · Cited by 292
Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
Bertini, R., Bianchi, M., & Ghezzi, P. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1708 · Cited by 291
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., & Ryffel, B. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1437 · Cited by 290
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Stoll, L. L., Denning, G. M., & Weintraub, N. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000147534.69062.dc · Cited by 288
Transcriptional regulation of the endothelin-1 gene by TNF-alpha
Marsden, P. A., & Brenner, B. M. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.4.c854 · Cited by 287
The protein C anticoagulant pathway.
Esmon, C. T. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.135 · Cited by 287
Kettelhut, I. C., Fiers, W., & Goldberg, A. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4273 · Cited by 286
Stimulation of monokine production by lipoteichoic acids
Bhakdi, S., Klonisch, T., Nuber, P., & Fischer, W. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4614-4620.1991 · Cited by 286
Infections and anti–tumor necrosis factor α therapy
Ellerin, T., Rubin, R. H., & Weinblatt, M. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11301 · Cited by 284
Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in Rats
Kips, J. C., Tavernier, J., & Pauwels, R. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_1.332 · Cited by 284
Lehner, M. D., Morath, S., Michelsen, K. S., Schumann, R. R., & Hartung, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5161 · Cited by 283
Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF release
Ding, A. H., Porteu, F., Sanchez, E., & Nathan, C. F. (1990) · Science · doi:10.1126/science.1970196 · Cited by 281
ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE
Muto, Y., Meager, A., Nouri-Aria, K., Alexander, G. M., Eddleston, A. W. F., & Williams, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90006-2 · Cited by 280
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
REVIEW ARTICLE: THE ROLE OF TUMOR NECROSIS FACTOR IN RENAL ISCHEMIA-REPERFUSION INJURY
DONNAHOO, K. K., SHAMES, B. D., HARKEN, A. H., & MELDRUM, D. R. (1999) · Journal of Urology · doi:10.1097/00005392-199907000-00068 · Cited by 279
IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin
Swantek, J. L., Tsen, M. F., Cobb, M. H., & Thomas, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4301 · Cited by 279
Pagani, F. D., Baker, L. S., Hsi, C., Knox, M., Fink, M. P., & Visner, M. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115873 · Cited by 278
Havell, E. A., Fiers, W., & North, R. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1067 · Cited by 276
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamow, S. M., Figari, I. S., Pennica, D., Goeddel, D. V., Palladino, M. A., & Smith, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10535 · Cited by 275
Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?
Dyson, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181922bd3 · Cited by 273
Bagby, G. J., Plessala, K. J., Wilson, L. A., Thompson, J. J., & Nelson, S. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.83 · Cited by 273
How TNF was recognized as a key mechanism of disease
CLARK, I. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.002 · Cited by 271
Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum
Warren, H. S., Fitting, C., Hoff, E., Adib‐Conquy, M., Beasley‐Topliffe, L., Tesini, B., Liang, X., Valentine, C., Hellman, J., Hayden, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649557 · Cited by 269
Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?
Netea, M. G., van Deuren, M., Kullberg, B. J., Cavaillon, J.-M., & Van der Meer, J. W. M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02169-x · Cited by 268
Cytokines and Metabolic Dysfunction After Severe Head Injury
OTT, L., McCLAIN, C. J., GILLESPIE, M., & YOUNG, B. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.447 · Cited by 266
Tumor‐Necrosis Factor and other Cytokines in Cerebral Malaria: Experimental and Clinical Data
Grau, G. E., Piguet, P., Vassalli, P., & Lambert, P. (1989) · Immunological Reviews · doi:10.1111/j.1600-065x.1989.tb00552.x · Cited by 265
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Marshall, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1084 · Cited by 264
Calandra, T., Glauser, M. P., Schellekens, J., & Verhoef, J. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.2.312 · Cited by 263
Rothstein, J. L., & Schreiber, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.607 · Cited by 260
OXPENTIFYLLINE IN ENDOTOXAEMIA
ZABEL, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92929-2 · Cited by 259
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Josephs, S. F., Ichim, T. E., Prince, S. M., Kesari, S., Marincola, F. M., Escobedo, A. R., & Jafri, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1611-7 · Cited by 257
Differences in innate immune response between man and mouse
Zschaler, J., Schlorke, D., & Arnhold, J. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014011600 · Cited by 257
JÄÄTTELÄ, M., ILVESMÄKI, V., VOUTILAINEN, R., STENMAN, U.-H., & SAKSELA, E. (1991) · Endocrinology · doi:10.1210/endo-128-1-623 · Cited by 243
Ubiquitin in the immune system
Zinngrebe, J., Montinaro, A., Peltzer, N., & Walczak, H. (2014) · The EMBO Reports · doi:10.1002/embr.201338025 · Cited by 227
Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection
Ruzek, M. C., Pearce, B. D., Miller, A. H., & Biron, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3527 · Cited by 153
Acute mesenteric ischemia: Pathophysiology, diagnosis, and treatment
Benjamin, E., & Oropello, J. M. (1993) · Disease-a-Month · doi:10.1016/0011-5029(93)90023-v · Cited by 150
Tumor Necrosis Factor and Wound Healing
MOONEY, D. P., OʼREILLY, M., & GAMELLI, R. L. (1990) · Annals of Surgery · doi:10.1097/00000658-199002000-00002 · Cited by 144
Wurfel, M. M., Park, W. Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R. E., & Martin, T. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2570 · Cited by 130
TNF-α induces a decrease in eNOS promoter activity
Neumann, P., Gertzberg, N., & Johnson, A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00378.2002 · Cited by 118
Metadata
- Authors
- Beutler, B., Milsark, I. W., & Cerami, A. C.
- Venue
- Science
- Published
- 1985-08-30
- Volume
- 229
- Issue
- 4716
- Pages
- 869-871
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1999246265
- Cited by
- 2,352
- References
- 10
- FWCI
- 29.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.